Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 15, 2025
National Association of Specialty Pharmacy Congratulates Industry Award Winners at its Record-Breaking 2025 Annual Meeting & Expo
Washington, DC, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) announces Industry Award winners at its record-breaking 2025 Annual Meeting …
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 15 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a …
Organic & Natural Health Leads First-Ever My Health Alliance Lobby Day on Capitol Hill
WASHINGTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- On Sept. 10, more than 50 citizen lobbyists representing a consortium of 15 national nonprofits and organizations gathered on Capitol Hill for the first My Health Alliance Lobby Day, organized by the Organic …
Smile Hair Clinic Becomes the First Hair Transplant Clinic in the World to Receive A-Rated Certificate from TEMOS
ISTANBUL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Smile Hair Clinic has been awarded an A rating by TEMOS International Healthcare Accreditation, one of the most respected global organizations for quality and safety in healthcare. With this achievement, Smile …
ProteoNic Launches 2G UNic Transposon Platform to Support Superior Cell Line Productivity and Ease of Use
Leiden, The Netherlands – September 15, 2025 – ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon platform, available for licensing alongside the expansion …
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results in cases previously insufficient for testing by another commercially available molecular diagnostic test, helping avoid repeat FNAs Large …
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
PRESS RELEASE - 09/15/2025, 09:00 AM EDT Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test First-ever fully automated, sample-to-result, cartridge-based companion diagnostic test approved in the US for colorectal cancer patients Itasca (IL), …
Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
Preclinical Data for OPK-8801003 Demonstrate Substantially Longer Biological Half-Life with Peak Plasma Levels Comparable to Gattex®, the Only Approved GLP-2 Therapy Oral GLP-2 Tablet Could Transform Treatment Paradigm for 30,000 Short Bowel Syndrome (SBS) …
Berry Street Launches GLP-1 Nutrition Pathway Program
NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Berry Street, an AI-powered nutrition therapy platform, today announced the launch of its GLP-1 Nutrition Pathway Program, a comprehensive, structured program designed to promote preventative health, and improve …
Conceivable Life Sciences asegura $50 millones de dólares en ronda de financiación Serie A
La startup de biotecnología lidera desde México la revolución en medicina reproductiva con AURA, el primer laboratorio de Fecundación In Vitro (FIV) automatizado y potenciado por inteligencia artificial (IA) Con esta inversión, Conceivable se convierte en …
Conceivable Life Sciences Secures $50 Million Series A
NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Conceivable Life Sciences today announced its $50 million Series A financing to accelerate the development and commercialization of the world's first AI-powered automated IVF laboratory. The funding will support …
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
New data show how Sympazan is being used in daily clinical practice to treat patients with Lennox-Gastaut Syndrome (LGS), a severe form of childhood-onset epilepsy Study addresses lack of awareness and real-world data with oral film formulation of clobazam …
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the …
More than 3.7 Million Teens Participate in Planet Fitness' High School Summer Pass™ Program, Building Lifelong Health and Wellness Habits Through Fitness
TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Planet Fitness, one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, announced record-breaking participation in its 2025 High School …
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
SYDNEY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces the successful conduct of its scheduled Type C meeting (written response) on Alzheimer’s disease (AD) with the US Food …
KFSHRC Reduces Emergency Department Inpatient Bed Waiting Time by 75%
RIYADH, Saudi Arabia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has reduced the median emergency department boarding time from over 13 hours in 2023 to just 3.2 hours by mid 2025, achieving a …
Request for Secretary of State of Texas, Jane Nelson, to Organize a Public Meeting Between Crosetto and CPRIT Scientists Who Have Allocated $3.65 Billion of $6 Billion to Cancer Research
DALLAS, Sept. 15, 2025 (GLOBE NEWSWIRE) -- (In PDF https://bit.ly/3VPIFvY) The Crosetto Foundation for the Reduction of Cancer Deaths, a registered nonprofit with North Texas Giving Day (https://www.northtexasgivingday.org/organization/1951), has earned …